ITU Unit Action

ABRYSVO

Pfizer Inc.

ITU Unit Action

Trademark Snap Shot ITU Unit Action
(Table presents the data on ITU Unit Action)

OVERVIEW

SERIAL NUMBER 97018602 FILING DATE 09/09/2021
REG NUMBER 0000000 REG DATE N/A
REGISTER PRINCIPAL MARK TYPE TRADEMARK
INTL REG # N/A INTL REG DATE N/A
TM ATTORNEY BULLOFF, TOBY ELLEN
L.O. ASSIGNED 119

PUB INFORMATION

RUN DATE 01/07/2023
PUB DATE 07/05/2022
STATUS 730-FIRST EXTENSION - GRANTED
STATUS DATE 01/05/2023
LITERAL MARK ELEMENT ABRYSVO

DATE ABANDONED N/A DATE CANCELLED N/A
SECTION 2F NO SECTION 2F IN PART NO
SECTION 8 NO SECTION 8 IN PART NO
SECTION 15 NO REPUB 12C N/A
RENEWAL FILED NO RENEWAL DATE N/A
DATE AMEND REG N/A


FILING BASIS

FILED BASIS CURRENT BASIS AMENDED BASIS
1 (a) NO 1 (a) NO 1 (a) NO
1 (b) YES 1 (b) YES 1 (b) NO
44D NO 44D NO 44D NO
44E NO 44E NO 44E NO
66A NO 66A NO

NO BASIS NO NO BASIS NO


MARK DATA

STANDARD CHARACTER MARK YES
LITERAL MARK ELEMENT ABRYSVO
MARK DRAWING CODE 4-STANDARD CHARACTER MARK
COLOR DRAWING FLAG NO

CURRENT OWNER INFORMATION

PARTY TYPE 20-OWNER AT PUBLICATION
NAME Pfizer Inc.
ADDRESS 235 East 42nd Street
New York, NY 10017
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

GOODS AND SERVICES

INTERNATIONAL CLASS 005
          DESCRIPTION TEXT Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use

GOODS AND SERVICES CLASSIFICATION

INTERNATIONAL CLASS 005 FIRST USE DATE NONE FIRST USE IN COMMERCE DATE NONE CLASS STATUS 6-ACTIVE

MISCELLANEOUS INFORMATION/STATEMENTS

CHANGE IN REGISTRATION NO

PROSECUTION HISTORY

DATE ENT CD ENT TYPE DESCRIPTION ENT NUM
01/07/2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED 012
01/05/2023 EX1G S SOU EXTENSION 1 GRANTED 011
01/05/2023 EXT1 S SOU EXTENSION 1 FILED 010
01/05/2023 EEXT I TEAS EXTENSION RECEIVED 009
08/30/2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT 008
07/05/2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED 007
07/05/2022 PUBO A PUBLISHED FOR OPPOSITION 006
06/15/2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED 005
05/27/2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER 004
05/26/2022 DOCK D ASSIGNED TO EXAMINER 003
10/18/2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM 002
09/13/2021 NWAP I NEW APPLICATION ENTERED IN TRAM 001

CURRENT CORRESPONDENCE INFORMATION

ATTORNEY Richard A. Friedman
CORRESPONDENCE ADDRESS Richard A. Friedman
PFIZER INC.
235 EAST 42ND STREET
NEW YORK NY 10017
DOMESTIC REPRESENTATIVE NONE

PRIOR OWNER INFORMATION

PARTY TYPE 10-ORIGINAL APPLICANT
NAME Pfizer Inc.
ADDRESS 235 East 42nd Street
New York, NY 10017
ENTITY 03-CORPORATION
CITIZENSHIP Delaware

ITU Unit Action [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed